Jun-jiang Chen
Guangzhou, 510632, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Dual Role of the NFATc2/galectin-9 Axis in Modulating Tumor-Initiating Cell Phenotypes and Immune Suppression in Lung Adenocarcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 25, 2023
Correction to "BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo".
Journal: Molecular pharmaceutics
Published: May 15, 2023
Photonic Nanojet-Mediated Optogenetics.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 23, 2022
Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 13, 2022
Potassium channel-related genes are a novel prognostic signature for the tumor microenvironment of renal clear cell carcinoma.
Journal: Frontiers in oncology
Published: August 06, 2022
Resveratrol enhanced chemosensitivity by reversing macrophage polarization in breast cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 16, 2021
Photonic Nanojet-Mediated Optogenetics.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 16, 2021
Activation of the epithelial sodium channel (ENaC) leads to cytokine profile shift to pro-inflammatory in labor.
Journal: EMBO molecular medicine
Published: August 30, 2018
bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10).
Journal: PloS one
Published: January 24, 2013
BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo.
Journal: Molecular pharmaceutics
Published: October 11, 2012
Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.
Journal: PloS one
Published: September 13, 2012
Tandutinib (MLN518/CT53518) targeted to stem-like cells by inhibiting the function of ATP-binding cassette subfamily G member 2.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: September 10, 2012
Last Updated: 09/26/2026